[HTML][HTML] Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - Nature medicine, 2021 - nature.com
Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with
a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in …

[HTML][HTML] Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid …

…, H Wilkens, U Sester, M Sester, J Mihm - American Journal of …, 2021 - Elsevier
Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were …

[HTML][HTML] Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous …

V Klemis, T Schmidt, D Schub, J Mihm, S Marx… - Nature …, 2022 - nature.com
Comparative analyses of the immunogenicity and reactogenicity of homologous and
heterologous SARS-CoV-2 vaccine-regimens will inform optimized vaccine strategies. Here we …

[HTML][HTML] High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19

D Schub, V Klemis, S Schneitler, J Mihm, PM Lepper… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
differ in the severity of disease. We hypothesized that characteristics of SARS-…

Immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost vaccination compared with homologous vaccine regimens

T Schmidt, V Klemis, D Schub, J Mihm, F Hielscher… - MedRxiv, 2021 - medrxiv.org
Heterologous priming with the ChAdOx1-nCoV-19 vector-vaccine followed by boosting with
an mRNA-vaccine is currently recommended in Germany, although data on immunogenicity …

A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions

…, D Urlaub, CS Falk, M Claus, J Mihm… - Proceedings of the …, 2013 - National Acad Sciences
The E3 transcription unit of human adenoviruses (Ads) encodes immunomodulatory proteins.
Interestingly, the size and composition of the E3 region differs considerably among Ad …

[HTML][HTML] Potent induction of humoral and cellular immunity after bivalent BA. 4/5 mRNA vaccination in dialysis patients

S Bronder, J Mihm, R Urschel, V Klemis, T Schmidt… - npj Vaccines, 2024 - nature.com
Abstract Knowledge on immunogenicity of the bivalent Omicron BA.4/5 vaccine in dialysis
patients and the effect of a previous infection is limited. Therefore, vaccine-induced humoral …

Donor‐specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation

…, J Elsäßer, M Janssen, J Mihm… - European Journal of …, 2017 - Wiley Online Library
Preformed cellular alloreactivity can exist prior to transplantation and may contribute to
rejection. Here, we used a rapid flow‐cytometric whole‐blood assay to characterize the extent of …

Cellular immunity predominates over humoral immunity after the first dose of COVID-19 vaccines in solid organ transplant recipients

…, MC Reichert, H Wilkens, U Sester, M Sester, J Mihm - medRxiv, 2021 - medrxiv.org
Abstract Knowledge on the vaccine-induced cellular and humoral immunity and on
immunogenicity of vector-based and mRNA vaccines in solid organ transplant recipients is limited. …

[HTML][HTML] Old for young kidney transplantation: a responsible option for our patients to reduce waiting time?

P Zeuschner, J Mihm, U Sester, M Stöckle… - World Journal of …, 2024 - Springer
Purpose The Eurotransplant Senior program allocating grafts from donors≥ 65 years to
recipients aged≥ 65 years has proven good results within the last 20 years. However,“old” …